Changes to UnitedHealth Drug Formulary List Includes Biosimilar Drugs

On Wednesday, UnitedHealth announced their proposed changes to their drug formulary list which include excluding Sanofi’s insulin Lantus and Amgen’s infection-fighter Neupogen in favor of their biosimilars. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.